🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to evaluate the safety and efficacy of on...
Status
Completed
Location
The Second People's Hospital of Hefei
Start Date
2020-12-07
Trial ID
NCT04591626
Treatments Being Tested
The main purpose of this study is to evaluate the efficacy and safety of LY...
Status
Completed
Location
Syed Research Consultants Llc
Start Date
2021-05-13
Trial ID
NCT04867785
Treatments Being Tested
The main purpose of this study is to determine the side effects related to ...
Status
Completed
Location
Anaheim Clinical Trials, LLC
Start Date
2020-08-25
Trial ID
NCT04515576
Treatments Being Tested
The purpose of this study is to assess the effects of 2 doses of LY2189265 ...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-06
Trial ID
NCT01149421
Primary Objective: To demonstrate the superiority of the insulin glargine/...
Status
Completed
Location
Investigational Site Number 8400064
Start Date
2016-07-06
Trial ID
NCT02787551
The purpose of the trial is to assess the efficacy and safety of tirzepatid...
Status
Completed
Location
University of Alabama at Birmingham Medical Center
Start Date
2020-05-29
Trial ID
NCT04255433
Treatments Being Tested
This study is a multicenter, randomized, double-blind (with open-label dose...
Status
Recruiting
Location
Peking University People's Hospital
Start Date
2025-04-30
Trial ID
NCT07109700
This is a study to demonstrate that different doses of once-weekly LY218926...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2008-12
Trial ID
NCT00791479
Treatments Being Tested
The main purpose of this study is to assess dose-response characteristics i...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2009-10
Trial ID
NCT01001104
The main purpose of this study is to evaluate safety of dulaglutide in part...
Status
Completed
Location
Medlink Hospital Opp Someshwara Jain Temple
Start Date
2022-12-29
Trial ID
NCT05659537
Treatments Being Tested